The participants underwent neuropsychological assessments and fecal microbiota analysis through 16S ribosomal RNA (rRNA) Illumina Miseq sequencing technique ... were selected to be in the range of 250 ...

3. New Product Launches: The introduction of the MiSeq i100 series aims to expand Illumina’s total addressable market by making it easier for new NGS customers to enter the market. 4.

Illumina's commitment to increasing the sustainability of its business and products was further demonstrated in 2024 with the launch of the MiSeq i100 Series, which included key innovations ...

Illumina's commitment to increasing the sustainability of its business and products was further demonstrated in 2024 with the launch of the MiSeq i100 Series, which included key innovations, such as ...

Over the past year, the shadow of the Grail deal has hung over Illumina despite its reinvigorated leadership and launch of new partnerships or products, namely the MiSeq i100 benchtop sequencer.

Illumina's innovation pipeline remains a critical factor in its future success. The company recently announced the MiSeq i100 series, which analysts believe could significantly expand Illumina's ...

Illumina slashes costs by $100 million after China bans its sequencers. The company lowers its 2025 EPS outlook and aims for ...

Illumina recently launched the MiSeq i100 and MiSeq i100 Plus Systems, two powerful, compact benchtop sequencers that incorporate more than 140 invention disclosures and 60 patent families.

RBC Capital lowered the firm’s price target on Illumina (ILMN) to $128 from $247 but keeps an Outperform rating on the shares. The company’s ...